YS Biopharma Co., Ltd. announced at the extraordinary general meeting held on February 22, 2024, the shareholders voted in favor of each of the following resolutions: that the appointment of each of Haitao Zhao, Henry Chen, Pierson Yue Pan, Yuntao Cui, Jin Wang, Chunyuan (Brenda) Wu as a director of the Company is hereby reaffirmed, ratified and confirmed in all respects. the Company is hereby authorized and directed to remove Mr. Yi Zhang from all positions with the Company and any subsidiaries of the Company, including without limitation as director, officer and/or legal representative.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.835 USD | -7.22% | -18.14% | +63.41% |
May. 28 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
May. 24 | YS Biopharma to Become LakeShore Biopharma, Ticker Symbol to Change to LSB From YS Starting May 28 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.41% | 157M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- LSB Stock
- News LakeShore Biopharma Co., Ltd
- YS Biopharma Co., Ltd. Announces Board Changes